Actively targeted chitosan-based vector for efficient CRISPR-Cas9 mediated Tenascin-C gene editing in triple negative breast cancer
| dc.contributor.author | Bareke, H. | |
| dc.contributor.author | Fuentes, M. | |
| dc.contributor.author | Oladipo, A. A. | |
| dc.contributor.author | Ozbas, S. | |
| dc.contributor.author | Salva, E. | |
| dc.date.accessioned | 2026-02-06T18:28:45Z | |
| dc.date.issued | 2021 | |
| dc.department | Doğu Akdeniz Üniversitesi | |
| dc.description | European-Society-of-Gene-and-Cell-Therapy Collaborative Virtual Congress (ESGCT) -- OCT 19-22, 2021 -- ELECTR NETWORK | |
| dc.description.abstract | [Abstract Not Available] | |
| dc.description.sponsorship | Inonu University, Department of Scientific Research Projects [TOA-2019-1543] | |
| dc.description.sponsorship | The research was funded by Inonu University, Department of Scientific Research Projects (TOA-2019-1543). | |
| dc.description.sponsorship | European Soc Gene & Cell Therapy | |
| dc.identifier.endpage | A36 | |
| dc.identifier.issn | 1043-0342 | |
| dc.identifier.issn | 1557-7422 | |
| dc.identifier.issue | 19-20 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | A36 | |
| dc.identifier.uri | https://hdl.handle.net/11129/11078 | |
| dc.identifier.volume | 32 | |
| dc.identifier.wos | WOS:001023133000100 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.language.iso | en | |
| dc.publisher | Mary Ann Liebert, Inc | |
| dc.relation.ispartof | Human Gene Therapy | |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20260204 | |
| dc.title | Actively targeted chitosan-based vector for efficient CRISPR-Cas9 mediated Tenascin-C gene editing in triple negative breast cancer | |
| dc.type | Conference Object |










